Neil G A, Sammons D W
Department of Internal Medicine, University of Iowa, Iowa City 52242.
Hum Antibodies Hybridomas. 1992 Oct;3(4):201-5.
Human hybridomas with specificity for recombinant hepatitis B surface antigen (HBSAg) were produced by adoptive transfer of human peripheral blood mononuclear cells prepared from HBSAg-immune donors to CB.17 mice bearing the severe combined immunodeficiency (SCID) phenotype. A total of ten SCID-Hu mice were immunized with recombinant HBSAg. Eight SCID-Hu mice found to have human HBSAg antibody in their serum were sacrificed, and single-cell suspensions were made from their spleens. The SCID-Hu spleen cells were electrofused to the mouse-human fusion partner H7. HBSAg-specific hybridomas were recovered from all fusions. This method may provide the means for the production of other human hybridomas and may, in some cases, circumvent the need for in vitro immunization or Epstein-Barr virus transformation of human B lymphocytes.
通过将从乙肝表面抗原(HBSAg)免疫供体中制备的人外周血单核细胞过继转移至具有严重联合免疫缺陷(SCID)表型的CB.17小鼠体内,产生了对重组乙肝表面抗原具有特异性的人杂交瘤。总共10只SCID-Hu小鼠用重组HBSAg进行免疫。处死8只血清中发现有人HBSAg抗体的SCID-Hu小鼠,并从其脾脏制备单细胞悬液。将SCID-Hu脾细胞与小鼠-人融合伴侣H7进行电融合。从所有融合产物中获得了HBSAg特异性杂交瘤。该方法可能为生产其他人类杂交瘤提供手段,并且在某些情况下,可能无需对人B淋巴细胞进行体外免疫或爱泼斯坦-巴尔病毒转化。